Funding to study the comparative effectiveness of healthcare treatments, including drugs, is part of the
stimulus package Congress is considering now that lawmakers have recommended $1.1 billion to support such research. Comparative effectiveness studies that take the costs and effectiveness of drugs into account could affect sales of specific products.
Washington Drug Letter